Evaluation of a Specialist Nurse-Led Post-Coronary Heart Disease Support Program: A Prospective Pre–Post Interventional Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Sampling and Research Procedures
2.3. Research Instruments
2.4. Evaluation of Nurse-Led Post-CHD Support Program
2.5. Ethical Considerations
2.6. Statistical Analysis
3. Results
4. Discussion
Future Implications
5. Limitations
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Safiri, S.; Karamzad, N.; Singh, K.; Carson-Chahhoud, K.; Adams, C.; Nejadghaderi, S.A.; Almasi-Hashiani, A.; Sullman, M.J.M.; Mansournia, M.A.; Bragazzi, N.L.; et al. Burden of Ischemic Heart Disease and Its Attributable Risk Factors in 204 Countries and Territories, 1990–2019. Eur. J. Prev. Cardiol. 2022, 29, 420–431. [Google Scholar] [CrossRef] [PubMed]
- Zhang, G.; Yu, C.; Zhou, M.; Wang, L.; Zhang, Y.; Luo, L. Burden of Ischaemic Heart Disease and Attributable Risk Factors in China from 1990 to 2015: Findings from the Global Burden of Disease 2015 Study. BMC Cardiovasc. Disord. 2018, 18, 18. [Google Scholar] [CrossRef] [PubMed]
- Ni, Y.; Wen, Y.; Bao, Y.; Xu, Y.; Chen, Z.; Yang, X.; He, J.; You, G. Nurses’ Perspectives on the Barriers to and Facilitators of the Implementation of Secondary Prevention for People with Coronary Heart Disease: A Qualitative Descriptive Study. BMJ Open 2022, 12, e063029. [Google Scholar] [CrossRef] [PubMed]
- Kavita, K.; Thakur, J.S.; Vijayvergiya, R.; Ghai, S. Nurses Role in Cardiovascular Risk Assessment and Communication: Indian Nurses Perspective. Int. J. Noncommun. Dis. 2020, 5, 4. [Google Scholar] [CrossRef]
- Park, M.; Song, R.; Jeong, J.-O. Effect of goal attainment theory-based education program on cardiovascular risks, behavioral modification, and quality of life among patients with first episode of acute myocardial infarction: Randomized study. Int. J. Nurs. Stud. 2017, 71, 8–16. [Google Scholar] [CrossRef]
- Ram, R.; Trivedi, A. Behavioral risk factors of coronary artery disease: A paired matched case control study. J. Cardiovasc. Dis. Res. 2012, 3, 212–217. [Google Scholar] [CrossRef]
- Jiang, W.; Zhang, Y.; Yan, F.; Liu, H.; Gao, R. Effectiveness of a nurse-led multidisciplinary self-management program for patients with coronary heart disease in communities: A randomized controlled trial. Patient Educ. Couns. 2020, 103, 854–863. [Google Scholar] [CrossRef]
- Thomas, R.J. Cardiac rehabilitation/secondary prevention programs: A raft for the rapids: Why have we missed the boat? Circulation 2007, 116, 1644–1646. [Google Scholar] [CrossRef]
- Smigorowsky, M.J.; Sebastianski, M.; Sean McMurtry, M.; Tsuyuki, R.T.; Norris, C.M. Outcomes of nurse practitioner-led care in patients with cardiovascular disease: A systematic review and meta-analysis. J. Adv. Nurs. 2020, 76, 81–95. [Google Scholar] [CrossRef]
- Moreno-Chico, C.; Roy, C.; Monforte-Royo, C.; González-De Paz, L.; Navarro-Rubio, M.D.; Gallart Fernández-Puebla, A. Effectiveness of a Nurse-Led, Face-to-Face Health Coaching Intervention in Enhancing Activation and Secondary Outcomes of Primary Care Users with Chronic Conditions. Res. Nurs. Health 2021, 44, 458–472. [Google Scholar] [CrossRef]
- Rezaee, M.; Darroudi, H.; Etemad, L.; Shad, A.N.; Zardast, Z.; Kohansal, H.; Ghayour-Mobarhan, M.; Sadeghian, F.; Moohebati, M.; Esmaily, H.; et al. Anxiety, a Significant Risk Factor for Coronary Artery Disease: What Is the Best Index. BMC Psychiatry 2024, 24, 443. [Google Scholar] [CrossRef] [PubMed]
- Puri, S.N.; Lalwani, L. A Comparison Between Cardiac Telerehabilitation Program and Outpatient Hospital-Based Cardiac Rehabilitation Program for Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery: A Review. Cureus 2024, 15, e48488. [Google Scholar] [CrossRef] [PubMed]
- 2010 Dietary Guidelines. Available online: https://odphp.health.gov/our-work/nutrition-physical-activity/dietary-guidelines/previous-dietary-guidelines/2010 (accessed on 23 November 2024).
- Lloyd-Jones, D.M.; Hong, Y.; Labarthe, D.; Mozaffarian, D.; Appel, L.J.; Van Horn, L.; Greenlund, K.; Daniels, S.; Nichol, G.; Tomaselli, G.F.; et al. American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: The American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation 2010, 121, 586–613. [Google Scholar] [CrossRef] [PubMed]
- Trejo, R.; Edward, K.; Cross, W. Referral of Individuals with Cardiovascular Disease to Secondary Prevention Programmes. Br. J. Nurs. 2018, 27, 314–320. [Google Scholar] [CrossRef]
- Deng, F.; Wang, Q.; Wen, X.; Xu, X.; Jia, L.; He, H.; Wang, X.; Xie, Y.; Li, H.; Qiao, L.; et al. Association between Body Mass Index and Serum Uric Acid: Mediation analysis involving liver enzymes indicators. BMC Public Health 2024, 24, 3007. [Google Scholar] [CrossRef]
- Ögmundsdottir Michelsen, H.; Nilsson, M.; Scherstén, F.; Sjölin, I.; Schiopu, A.; Leosdottir, M. Tailored Nurse-Led Cardiac Rehabilitation after Myocardial Infarction Results in Better Risk Factor Control at One Year Compared to Traditional Care: A Retrospective Observational Study. BMC Cardiovasc. Disord. 2018, 18, 167. [Google Scholar] [CrossRef]
- Visseren, F.L.J.; Mach, F.; Smulders, Y.M.; Carballo, D.; Koskinas, K.C.; Bäck, M.; Benetos, A.; Biffi, A.; Boavida, J.-M.; Capodanno, D.; et al. ESC Scientific Document Group. 2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice: Developed by the Task Force for Cardiovascular Disease Prevention in Clinical Practice with Representatives of the European Society of Cardiology and 12 Medical Societies with the Special Contribution of the European Association of Preventive Cardiology (EAPC). Eur. Heart J. 2021, 42, 3227–3337. [Google Scholar] [CrossRef]
- Zikos, D.; Diomidous, M.; Mantas, J.; Kaitelidou, D.; Karanikolos, M. Greece. In Strengthening Health Systems Through Nursing: Evidence From 14 European Countries; Rafferty, A.M., Busse, R., Zander-Jentsch, B., Sermeus, W., Bruyneel, L., Eds.; European Observatory Health Policy Series; European Observatory on Health Systems and Policies: Copenhagen, Denmark, 2019. [Google Scholar]
- Molloy, M.A.; Zhao, Y.; Leonard, C.; Chen, Y.; Cadavero, A.A.; Xing, W.; Vaughn, J.; Lin, Y.; Min, H.; Oermann, M.H.; et al. Nursing Students from China and United States: Learning Together through Virtual Simulation. Nurs. Educ. Perspect. 2022, 43, 171. [Google Scholar] [CrossRef]
- Cook, C.E.; Thigpen, C.A. Five Good Reasons to Be Disappointed with Randomized Trials. J. Man. Manip. Ther. 2019, 27, 63. [Google Scholar] [CrossRef]
- Siegle, D. Single Subject Research. Educational Research Basics by Del Siegle. Available online: https://researchbasics.education.uconn.edu/single-subject-research/ (accessed on 28 February 2015).
- Stout, K.K.; Daniels, C.J.; Aboulhosn, J.A.; Bozkurt, B.; Broberg, C.S.; Colman, J.M.; Crumb, S.R.; Dearani, J.A.; Fuller, S.; Gurvitz, M.; et al. 2018 AHA/ACC Guideline for the Management of Adults with Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019, 73, e81–e192. [Google Scholar] [CrossRef]
- Ministry of Health, General Secretarian of Health Services. Therapeutic Department, Protocols and Registries of Patients, Scientific Working Group of Cardiologists Diseases. Available online: https://www.moh.gov.gr/articles/health/domes-kai-draseis-gia-thn-ygeia/kwdikopoihseis/ (accessed on 20 November 2024).
- Angyan, S.; Jun, C.; Siwen, Z.; Guangxue, W. Nursing Interventions and Care Strategies for Patients with Coronary Heart Disease: A Comprehensive Review. Galen Med. J. 2023, 12, 1–13. [Google Scholar]
- Alben Sigamani, A.; Rajeev, G. Revisiting secondary prevention in coronary heart disease. Indian Heart J. 2022, 74, 431–440. [Google Scholar] [CrossRef] [PubMed]
- Ades, P.A. Cardiac rehabilitation and secondary prevention of coronary heart disease. N. Engl. J. Med. 2001, 345, 892–902. [Google Scholar] [CrossRef]
- Cui, E.R.; Fernandez, A.R.; Zegre-Hemsey, J.K.; Grover, J.M.; Honvoh, G.; Brice, J.H.; Rossi, J.S.; Patel, M.D. Disparities in Emergency Medical Services Time Intervals for Patients with Suspected Acute Coronary Syndrome: Findings from the North Carolina Prehospital Medical Information System. J. Am. Heart Assoc. 2021, 10, e019305. [Google Scholar] [CrossRef]
- Guest, G.; Namey, E.; Chen, M. A Simple Method to Assess and Report Thematic Saturation in Qualitative Research. PLoS ONE 2020, 15, e0232076. [Google Scholar] [CrossRef]
- Yang, L.; Luo, S.; Yang, S.; de Melo Ghisi, G.L.; Yan, X.; Tian, M.; Wu, Y. Validation of the Chinese Version of the Coronary Artery Disease Education Questionnaire—Short Version: A Tool to Evaluate Knowledge of Cardiac Rehabilitation Components. Glob. Heart 2021, 16, 17. [Google Scholar] [CrossRef]
- Roest, A.; Martens, E.; Jonge, P.; Denollet, J. Anxiety and Risk of Incident Coronary Heart Disease: A Meta-Analysis. JACC 2010, 56, 38–46. [Google Scholar] [CrossRef]
- Holopainen, G.; Nyström, L.; Kasén, A. The Caring Encounter in Nursing. Nurs. Ethics 2019, 26, 7–16. [Google Scholar] [CrossRef]
- Askin, L.; Uzel, K.E.; Tanrıverdi, O.; Kavalcı, V.; Yavcin, O.; Turkmen, S. The Relationship between Coronary Artery Disease and Depression and Anxiety Scores. N. Clin. Istanb. 2020, 7, 523–526. [Google Scholar] [CrossRef]
- Chang, Z.; Guo, A.-Q.; Zhou, A.-X.; Sun, T.-W.; Ma, L.; Gardiner, F.W.; Wang, L.-X. Nurse-Led Psychological Intervention Reduces Anxiety Symptoms and Improves Quality of Life Following Percutaneous Coronary Intervention for Stable Coronary Artery Disease. Aust. J. Rural Health 2020, 28, 124–131. [Google Scholar] [CrossRef]
- Martens, E.J.; Nyklícek, I.; Szsabo, B.M.; Kupper, N. Depression and anxiety as predictors of heart rate variability after myocardial infarc-tion. Psychol. Med. 2008, 38, 375–383. [Google Scholar] [CrossRef] [PubMed]
- Van den Broek, K.C.; Nyklícek, I.; van der Voort, P.H.; Alings, M.; Meijer, A.; Denollet, J. Risk of ventricular arrhythmia after implantable defibrillator treatment in anxious Type D patients. J. Am. Coll. Cardiol. 2009, 54, 531–537. [Google Scholar] [CrossRef] [PubMed]
- Celano, C.M.; Daunis, D.J.; Lokko, H.N.; Campbell, K.A.; Huffman, J.C. Anxiety Disorders and Cardiovascular Disease. Curr. Psychiatry Rep. 2016, 18, 101. [Google Scholar] [CrossRef] [PubMed]
- Koivula, M.; Tarkka, M.-T.; Tarkka, M.; Laippala, P.; Paunonen-Ilmonen, M. Fear and anxiety in patients at different time-points in the coronary artery bypass process. Int. J. Nurs. Stud. 2002, 39, 811–822. [Google Scholar] [CrossRef]
- Lissåker, C.T.; Wallert, J.; Held, C.; Olsson, E. Emotional distress as a predictor of statin non-adherence among Swedish first-time myocardial infarction patients, 2006–2013. J. Psychosom. Res. 2017, 97, 30–37. [Google Scholar] [CrossRef]
- Kronish, I.M.; Rieckmann, N.; Burg, M.M.; Alcántara, C.; Davidson, K.W. The psychosocial context impacts medication adherence after acute coronary syndrome. Annals of Behavioral Medicine. Ann. Behav. Med. 2014, 47, 158–164. [Google Scholar] [CrossRef]
- Ho, P.M.; Bryson, C.L.; Rumsfeld, J.S. Medication adherence: Its importance in cardiovascular outcomes. Circulation 2009, 119, 3028–3035. [Google Scholar] [CrossRef]
- Buckley, J.P.; Furze, G.; Doherty, P.; Speck, L.; Connolly, S.; Hinton, S. BACPR scientific statement: British standards and core components for cardiovascular disease prevention and rehabilitation. Heart 2013, 99, 1069–1071. [Google Scholar] [CrossRef]
- Jennings, C.; Astin, F.; Fitzsimons, D.; Lambrinou, E.; Neubeck, L.; Thompson, D.R. ESC Textbook of Cardiovascular Nursing; Oxford University Press: Oxford, UK, 2021. [Google Scholar]
- Natarajan, P.; Ray, K.; Cannon, C. High-Density Lipoprotein and Coronary Heart Disease: Current and Future Therapies. J. Am. Coll. Cardiol. 2010, 55, 1283–1299. [Google Scholar] [CrossRef]
- Laville, S.M.; Couturier, A.; Lambert, O.; Metzger, M.; Mansencal, N.; Jacquelinet, C.; Laville, M.; Frimat, L.; Fouque, D.; Combe, C.; et al. Urea levels and cardiovascular disease in patients with chronic kidney disease. Nephrol. Dial. Transplant. 2023, 38, 184–192. [Google Scholar] [CrossRef]
- Poznyak, A.; Litvinova, L.; Poggio, P.; Sukhorukov, V.; Orekhov, A. Effect of Glucose Levels on Cardiovascular Risk. Cells 2022, 11, 3034. [Google Scholar] [CrossRef] [PubMed]
- Yuichi Saito, Y.; Tanaka, A.; Node, K.; Kobayash, Y. Uric acid and cardiovascular disease: A clinical review. J. Cardiol. 2021, 78, 51–57. [Google Scholar] [CrossRef] [PubMed]
- Navar, A.M. The Evolving Story of Triglycerides and Coronary Heart Disease Risk. JAMA 2019, 321, 347–349. [Google Scholar] [CrossRef] [PubMed]
- Dézsi, C.A.; Szentes, V. The Real Role of β-Blockers in Daily Cardiovascular Therapy. Am. J. Cardiovasc. Drugs 2017, 17, 361. [Google Scholar] [CrossRef]
- Gorre, F.; Vandekerckhove, H. Beta-blockers: Focus on mechanism of action. Which beta-blocker, when and why? Acta Cardiol. 2010, 65, 565–570. [Google Scholar] [CrossRef]
- Khashayar, F.; Arif, J. Beta Blockers. StatPearls. Available online: https://www.ncbi.nlm.nih.gov/books/NBK532906/ (accessed on 22 August 2023).
- Graudins, A.; Lee, H.M.; Druda, D. Calcium channel antagonist and beta-blocker overdose: Antidotes and adjunct therapies. Br. J. Clin. Pharmacol. 2016, 81, 453–461. [Google Scholar] [CrossRef]
- Mancia, G.; Fagard, R.; Narkiewicz, K.; Redón, J.; Zanchetti, A.; Böhm, M.; Christiaens, T.; Cifkova, R.; De Backer, G.; Dominiczak, A.; et al. 2013 ESH/ESC Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 2013, 31, 1281. [Google Scholar] [CrossRef]
- Mulder, R.; Singh, A.B.; Hamilton, A. The limitations of using randomised controlled trials as a basis for developing treatment guidelines. Evid. Based Ment. Health 2018, 21, 4–6. [Google Scholar] [CrossRef]
Demographic Characteristics | Min | Max | M (SD) |
---|---|---|---|
Age | 34 | 94 | 68.5 ± (12.5) |
Group | Frequency | Percentage% | |
Sex | Male | 182 | 66.2 |
Female | 93 | 33.8 | |
Health History Characteristics | Group | Frequency | Percentage% |
Family History of CHD | No | 113 | 41.1 |
Yes | 162 | 58.9 | |
Coronary Artery Disease | Stable Angina | 67 | 24.4 |
Unstable Angina | 45 | 16.4 | |
AΜΙ STEMI | 91 | 33.1 | |
AΜΙ NSTEMI | 72 | 26.2 | |
Intervention (CABG, PCI, STENT) | No | 25 | 9.1 |
Yes | 250 | 90.9 | |
Diabetes | No | 173 | 62.9 |
Yes | 102 | 37.1 | |
Dyslipidemia | No | 48 | 17.5 |
Yes | 227 | 82.5 | |
Group | Frequency | Percentage% | |
Atrial Fibrillation | No | 210 | 76.4 |
Yes | 65 | 23.6 | |
Heart Failure | No | 154 | 56.0 |
Yes | 121 | 44.0 | |
Peripheral Arterial Disease | No | 208 | 75.6 |
Yes | 67 | 24.4 | |
Anxiety First Measurement | No | 2 | 0.7 |
Yes | 273 | 99.2 | |
Anxiety Second Measurement | No | 54 | 19.6 |
Yes | 221 | 80.3 | |
Call the Nurse Consultant between First and Second Measurement | No | 269 | 97.8 |
Yes | 6 | 2.2 |
First Measurements | Second Measurements | ||||||
---|---|---|---|---|---|---|---|
Psychological Measurements | N | M (SD) | N | M (SD) | %Mean Difference | p | |
Anxiety | Within normal range | 2 | 42.50 (1.50) | 54 | 41.98 (1.80) | −1.22% | 0.03 * |
Minimal to moderate | 112 | 54.27 (4.07) | 164 | 49.63 (3.56) | −8.55% | ||
Moderate to severe | 161 | 64.11 (3.40) | 48 | 67.60 (4.22) | +5.44% | ||
Severe | - | - | 9 | 76.89 (2.71) | - | ||
Behavioral Measurements | N | M (SD) | N | M (SD) | % Mean Difference | p | |
BMI | Normal | 53 | 22.75 (1.70) | 79 | 23.01 (1.44) | +1.14% | 0.00 ** |
Overweight | 128 | 27.52 (1.31) | 131 | 26.90 (1.23) | −2.25% | ||
Obesity | 94 | 33.69 (3.12) | 65 | 32.79 (2.47) | −2.67% | ||
Weight | Kilos | 275 | 86.17 (17.85) | 275 | 81.63 (15.71) | −5.27% | 0.00 ** |
N | % | N | % | % Difference | p | ||
Smoking | Never | 68 | 24.73 | 68 | 24.73 | 0 | 0.00 ** |
Former | 91 | 33.09 | 145 | 52.72 | +19.63% | ||
Current | 116 | 42.18 | 62 | 22.55 | −19.63% | ||
Alcohol consumption | No | 181 | 65.80 | 197 | 71.63 | +5.83% | 0.00 ** |
Yes | 94 | 34.20 | 78 | 28.37 | −5.83% | ||
Physical activity | No | 216 | 78.55 | 211 | 76.73 | −1.82% | 0.19 |
Yes | 59 | 21.45 | 64 | 23.27 | +1.82% | ||
Family engagement | No | 131 | 47.64 | 96 | 34.90 | −12.74% | 0.00 ** |
Yes | 144 | 52.36 | 179 | 65.10 | +12.74% | ||
Adherence to care plan | No | 58 | 21.10 | 30 | 10.90 | −10.20% | 0.00 ** |
Yes | 217 | 78.90 | 245 | 89.10 | +10.20% |
First Measurement | Second Measurement | |||||
---|---|---|---|---|---|---|
Dietary Factors | M (SD) | Min–Max | M (SD) | Min–Max | Paired Mean Difference (SD) | p |
Urea | 44.83 (24.74) | 4–267 | 40.9 (19.44) | 11–213 | 3.93 (12.28) | 0.000 ** |
Serum Glucose | 115.25 (39.64) | 63–371 | 102.9 (25.84) | 43–269 | 12.36 (28.71) | 0.000 ** |
Uric Acid | 5.43 (2.8) | 2.3 -12 | 4.88 (1.11) | 2.1–9.3 | 0.54 (2.55) | 0.000 ** |
Total Cholesterol | 163.27 (48.44) | 62–320 | 134.44 (40.99) | 71–287 | 28.83 (38.89) | 0.000 ** |
HDL | 49.62 (27.41) | 20–107 | 55.29 (12.97) | 21–87 | −5.67 (26.48) | 0.000 ** |
LDL | 102.92 (37.51) | 40–273 | 90.16 (30.68) | 39–291 | 12.76 (25.17) | 0.000 ** |
Triglycerides | 124.01 (63.66) | 45–492 | 106.77 (43.62) | 41–367 | 17.24 (42.75) | 0.000 ** |
AST | 32.19 (32.51) | 6–164 | 23.61 (12.36) | 7–93 | 8.58 (29.96) | 0.000 ** |
ALT | 29.29 (15.98) | 2–96 | 24.27 (16.02) | 7–140 | 5.02 (17.81) | 0.000 ** |
β | SE | Wald | p | |
---|---|---|---|---|
Intercept (α) | 10.88 | 2.00 | 29.58 | 0.00 ** |
Anxiety | −0.10 | 0.02 | 28.01 | 0.00 ** |
BMI | −0.09 | 0.06 | 2.46 | 0.12 |
Weight | −0.01 | 0.02 | 0.32 | 0.57 |
Smoking | 0.08 | 0.34 | 0.06 | 0.69 |
Physical activity | 0.73 | 0.42 | 3.03 | 0.10 |
Alcohol consumption | 0.09 | 0.34 | 0.06 | 0.80 |
Family engagement | −0.10 | 0.29 | 0.09 | 0.76 |
Adjustment variables | ||||
Sex (male vs. female) | −0.42 | 0.42 | 0.99 | 0.32 |
Age (years) | −0.01 | 0.01 | 0.05 | 0.83 |
Dyslipidemia (yes vs. no) | 0.94 | 0.38 | 6.22 | 0.01 ** |
Family history of CHD (yes vs. no) | −0.72 | 0.35 | 4.29 | 0.04 * |
M (SD) | M (SD) | t (275) | p | |
---|---|---|---|---|
Pulse Rate × B-Blockers | B-Blockers {YES} | B-Blockers {NO} | ||
5.86 (7.50) | 4.04 (6.50) | −2.12 | 0.03 * | |
Pulse Rate × Cardioselective B-Blockers | Cardioselective {YES} | Cardioselective {NO} | ||
6.34 (7.99) | 4.18 (6.36) | −2.47 | 0.01 ** | |
Pulse Rate × Cardioselective B-Blockers | Non Cardioselective | Non Cardioselective | ||
{YES} | {NO} | |||
4.61 (5.96) | 5.09 (7.29) | 0.39 | 0.69 ** |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Molos, I.; Kleisiaris, C.; Patelarou, A.; Kasimis, G.; Karavasileiadou, S.; Alanazi, A.; Leonidas, P.; Bakalis, N. Evaluation of a Specialist Nurse-Led Post-Coronary Heart Disease Support Program: A Prospective Pre–Post Interventional Study. Healthcare 2024, 12, 2497. https://doi.org/10.3390/healthcare12242497
Molos I, Kleisiaris C, Patelarou A, Kasimis G, Karavasileiadou S, Alanazi A, Leonidas P, Bakalis N. Evaluation of a Specialist Nurse-Led Post-Coronary Heart Disease Support Program: A Prospective Pre–Post Interventional Study. Healthcare. 2024; 12(24):2497. https://doi.org/10.3390/healthcare12242497
Chicago/Turabian StyleMolos, Ilias, Christos Kleisiaris, Athina Patelarou, George Kasimis, Savvato Karavasileiadou, Alaa Alanazi, Poulimenos Leonidas, and Nikolaos Bakalis. 2024. "Evaluation of a Specialist Nurse-Led Post-Coronary Heart Disease Support Program: A Prospective Pre–Post Interventional Study" Healthcare 12, no. 24: 2497. https://doi.org/10.3390/healthcare12242497
APA StyleMolos, I., Kleisiaris, C., Patelarou, A., Kasimis, G., Karavasileiadou, S., Alanazi, A., Leonidas, P., & Bakalis, N. (2024). Evaluation of a Specialist Nurse-Led Post-Coronary Heart Disease Support Program: A Prospective Pre–Post Interventional Study. Healthcare, 12(24), 2497. https://doi.org/10.3390/healthcare12242497